Exogeneous metal ions as therapeutic agents in cardiovascular disease and their delivery strategies.
- Published in:
- Regenerative Biomaterials, 2024, v. 11, p. 1, doi. 10.1093/rb/rbad103
- By:
- Publication type:
- Article
Works by Tian, Geer
Results: 9
1
2
Inhibition of P2X7 Purinergic Receptor Ameliorates Cardiac Fibrosis by Suppressing NLRP3/IL-1β Pathway.
- Published in:
- Oxidative Medicine & Cellular Longevity, 2020, p. 1, doi. 10.1155/2020/7956274
- By:
- Publication type:
- Article
3
Mitochondrial ROS-Modulated mtDNA: A Potential Target for Cardiac Aging.
- Published in:
- Oxidative Medicine & Cellular Longevity, 2020, p. 1, doi. 10.1155/2020/9423593
- By:
- Publication type:
- Article
4
P2Y1 Receptor Agonist Attenuates Cardiac Fibroblasts Activation Triggered by TGF-β1.
- Published in:
- Frontiers in Pharmacology, 2021, v. 11, p. N.PAG, doi. 10.3389/fphar.2021.627773
- By:
- Publication type:
- Article
5
Therapeutic Antitumor Efficacy of Cancer Stem Cell-Derived DRibble Vaccine on Colorectal Carcinoma.
- Published in:
- International Journal of Medical Sciences, 2021, v. 18, n. 14, p. 3249, doi. 10.7150/ijms.61510
- By:
- Publication type:
- Article
6
Purinergic P2 Receptors: Novel Mediators of Mechanotransduction.
- Published in:
- Frontiers in Pharmacology, 2021, v. 11, p. N.PAG, doi. 10.3389/fphar.2021.671809
- By:
- Publication type:
- Article
7
Enhanced anticancer effect of oncostatin M combined with salinomycin in CD133<sup>+</sup> HepG2 liver cancer cells.
- Published in:
- Oncology Letters, 2019, v. 17, n. 2, p. 1798
- By:
- Publication type:
- Article
8
Identification of circular RNAs in cardiac hypertrophy and cardiac fibrosis.
- Published in:
- Frontiers in Pharmacology, 2022, v. 10, p. 1, doi. 10.3389/fphar.2022.940768
- By:
- Publication type:
- Article
9
Copper‐loaded Milk‐Protein Derived Microgel Preserves Cardiac Metabolic Homeostasis After Myocardial Infarction.
- Published in:
- Advanced Science, 2024, v. 11, n. 35, p. 1, doi. 10.1002/advs.202401527
- By:
- Publication type:
- Article